Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Panacea Medical Technologies Private Limited, is an unlisted private company incorporated on 26 March, 1999. It is classified as a private limited company and is located in Kolar, Karnataka. It's authorized share capital is INR 35.10 cr and the total paid-up capital is INR 33.10 cr.
Panacea Medical Technologies's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 44.86% over the previous year. At the same time, it's book networth has increased by 12.36%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Nominee Director | Bala C Deshpande | 00020130 | 10 years |
Nominee Director | Charles Antoine Janssen | 01266976 | 4 years |
Director | Ramann Yerramilli
Shareholder
|
02043813 | 22 years |
Managing Director | Venkata Subrahmanyam Goteti
Shareholder
|
02338270 | 26 years |
Director | Nagavalli Goteti
Shareholder
|
02488568 | 17 years |
Director | Satyalakshmi Goteti
Shareholder
|
03029412 | 20 years |
Nominee Director | Tarun Sharma | 03095034 | 10 years |
Kmp | Elizabeth Wilson | <HIDDEN> | 6 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 2
Total Amount : 36.8 cr
Technology Development Board
No. of Loans: 1
Total Amount : 16.4 cr
Union Bank of India
No. of Loans: 1
Total Amount : 15.0 cr
Export-Import Bank of India
No. of Loans: 1
Total Amount : 8.5 cr
Small Industries Development Bank of India
No. of Loans: 1
Total Amount : 7.5 cr
INCRED FINANCIAL SERVICES LIMITED
No. of Loans: 1
Total Amount : 5.0 cr
CASPIAN IMPACT INVESTMENTS PRIVATE LIMITED
No. of Loans: 1
Total Amount : 5.0 cr
SUPERGROWTH INVESTMENTS PRIVATE LIMITED
No. of Loans: 1
Total Amount : 2.7 cr
PROTIUM FINANCE LIMITED
No. of Loans: 2
Total Amount : 1.8 cr
UGRO CAPITAL LIMITED
No. of Loans: 2
Total Amount : 1.6 cr
Read more
The incorporation date of PANACEA MEDICAL TECHNOLOGIES PRIVATE LIMITED is 26 March, 1999
The authorized share capital of PANACEA MEDICAL TECHNOLOGIES PRIVATE LIMITED is INR ₹ 35.1 Cr.
The paid-up capital of PANACEA MEDICAL TECHNOLOGIES PRIVATE LIMITED is INR ₹ 33.1 Cr.
The registered address of PANACEA MEDICAL TECHNOLOGIES PRIVATE LIMITED is Plot No.35 4th Phase, KIADB Industrial Area NA Malur Kolar Karnataka - 563130
The CIN number of PANACEA MEDICAL TECHNOLOGIES PRIVATE LIMITED is U33112KA1999PTC079963.